Safety of self-injection of gold and methotrexate

Journal of Rheumatology

Volumn 26, Issue 2, 1999, Pages 302-305

  Arthur, Anne Barbara ^a   Klinkhoff, Alice V ^a,b   Teufel, Alvena ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Mary Pack Arthritis Centre   (Canada)

Author keywords

Gold; Methotrexate; Patient Education; Self administration; Self injection

Indexed keywords

GOLD; METHOTREXATE;

ADULT; ARTICLE; CLINICAL ARTICLE; COST CONTROL; DIARRHEA; DRUG SAFETY; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MOUTH ULCER; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT SATISFACTION; PRIORITY JOURNAL; PRURITUS; PSORIATIC ARTHRITIS; RASH; RHEUMATOID ARTHRITIS;

ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; FEMALE; GOLD COMPOUNDS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; METHOTREXATE; MIDDLE AGED; RISK ASSESSMENT; SELF ADMINISTRATION; TREATMENT OUTCOME;

EID: 0032925905     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Gross MLP, Kay J, Turner AM, Hallet K, Cleal AL, Hassani H. Sumatriptan in acute migraine using a novel cartridge system self-injector. Headache 1994;34:559-63.
2. York S, Kinney R, Taber TE. Self-administration of epoetin beta by peritoneal dialysis patients. Am Nephrol Nurse Assoc J 1991;18:549-52.
3. Valdevenito R, Melman A. Intracavernous self-injection pharmacotherapy program; analysis of results and complications. Int J Impot Res 1994;6:81-91.
4. Tugwell P, Boers M. OMERACT Committee. Proceedings of the OMERACT Conferences on Outcome Measures in Rheumatoid Arthritis Clinical Trials, Maastricht, Netherlands. J Rheumatol 1993;20:527-91.
5. Wolfe F. The curious case of intramuscular gold. Rheum Dis Clin North Am 1993;19:175-87.
6. Rau R, Herborn G, Menninger H, Blechschmidt J. Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis; 12 month data of double blind parallel study of 174 patients. Br J Rheumatol 1997;36:345-52.
7. Brooks PJ, Spruill WJ, Parish RC, Birchmore A. Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis. Arthritis Rheum 1990;33:91-4.
8. Freeman-Narrod M, Gerstley BJ, Engstrom PF. Comparison of serum concentrations of methotrexate after various routes of administration. Cancer 1975;36:1619-24.
9. Kamel RS, Al-Hakiem MH, Rademaker M, Meyrick Thomas RH, Munro DD. Pharmacokinetics of small doses of methotrexate in patients with psoriasis. Acta Derm Venereol (Stockh) 1988;267-70.
10. Campbell MA, Perrier DG, Dorr RT, Alberts DS, Finley PR. Methotrexate: bioavailability and pharmacokinetics. Cancer Treat Rep 1985;69:833-8.
11. Kremer JM, Alarcón GS, Weinblatt ME, et al. Clinical, laboratory, radiographic and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis. Arthritis Rheum 1997;40:1829-37.